Liquidia (LQDA) Net Margin Growth (1y) (2021 - 2026)
Liquidia (LQDA) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 372.00 |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -82.00 |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -538.00 |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | -2,930.00 |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 2,292.00 |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -146.00 |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 1,181.00 |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -2,359.00 |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 126,951.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 126,951.00 |
| Dec 31, 2025 | 133,601.00 |
| Sep 30, 2025 | 69,112.00 |
| Jun 30, 2025 | 31,298.00 |
| Mar 31, 2025 | -21,750.00 |
| Dec 31, 2024 | -71,437.00 |
| Sep 30, 2024 | -26,831.00 |
| Jun 30, 2024 | -29,212.00 |
| Mar 31, 2024 | -80,224.00 |
| Dec 31, 2023 | -48,394.00 |
| Sep 30, 2023 | -14,204.00 |
| Jun 30, 2023 | -25,025.00 |
| Mar 31, 2023 | 21,804.00 |
| Dec 31, 2022 | 23,777.00 |
| Sep 30, 2022 | -5,823.00 |
| Jun 30, 2022 | -4,704.00 |
| Mar 31, 2022 | -13,196.00 |
| Dec 31, 2021 | 181,529.00 |